FUNDACION PUBLICA MIGUEL SERVET -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2012
Criterium:Position:
Overall Score:900-1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 7
As coordinator: 0
As participant: 7
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 3.797.563 375.000 1
2021 0 2.281.840 22.940 1
2020 0 14.895.477 882.500 3
2013 0 6.000.000 269.990 1
2012 0 5.987.266 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
ORGANISMO AUTONOMO INSTITUTO DE SALUD PUBLICA Y LABORAL DE NAVARRA2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
UNIVERSITAETSKLINIKUM FREIBURG2
ABBVIE INC1
ADELPHI VALUES1
AGENCE NATIONALE DE SANTE PUBLIQUE1
ASOCIACION INSTITUTO BIODONOSTIA1
ASSOCIAZIONE IBLEA PER LA RICERCA EPIDEMIOLOGICA ONLUS1
AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO1
BAYER1
BERNHARD NOCHT INSTITUT FUER TROPENMEDIZIN1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BRAINSHAKE OY1
CANTACUZINO INSTITUTE OF RESEARCH DEVELOPMENT FOR MICROBIOLOGY AND IMMUNOLOGY1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER1
CENTRE HOSPITALIER UNIVERSITAIRE DE RENNES1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CENTRO DE INVESTIGACIONES ENERGETICAS MEDIOAMBIENTALES Y TECNOLOGICAS1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONCENTRIS RESEARCH MANAGEMENT1
CONSEJERIA DE SALUD Y SERVICIOS SANITARIOS PRINCIPADO DE ASTURIAS1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
CONSORCIO MAR PARC DE SALUT DE BARCELONA1
CR2O BV1
DEPARTMENT OF HEALTH1
DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
EPICONCEPT1
EPICONCEPT UK LIMITED1
ESCUELA ANDALUZA DE SALUD PUBLICA1
ESD EVALUATION SOFTWARE DEVELOPMENT1
EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER1
EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE1
EUROPEAN LIVER PATIENTS ASSOCIATION1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY1
FIRALIS SAS1
FOLKHALSOMYNDIGHETEN1
FOUNDATION FOR GENOMICS & POPULATION HEALTH1
FUNDACIO DE RECERCA CLINIC BARCELONAINSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
FUNDACION PARA LA FORMACION E INVESTIGACION SANITARIAS DE LA REGION DE MURCIA1
FUNDACION PARA LA INVESTIGACION BIOSANITARIA DE ANDALUCIA ORIENTALALEJANDRO OTERO1
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA1
GREENPHARMA S A1
HEALTH SERVICE EXECUTIVE HSE1
HELLENIC HEALTH FOUNDATION1
HOSPICES CIVILS DE LYON1
HOSPITAL CLINIC DE BARCELONA1
HUMAN GENETICS FOUNDATION1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INNOVATIVE TECHNOLOGIES IN BIOLOGICAL SYSTEMS1
INSERM TRANSFERT1
INSTITUT CATALA DE LA SALUT1
INSTITUT PASTEUR1
INSTITUTE OF PUBLIC HEALTH1
INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD1
INSTITUTO DE SALUD CARLOS III1
INSTITUTO NACIONAL DE SAUDE DR RICARDO JORGE1
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER1
IRCCS AZIENDA OSPEDALIERO UNIVERSITARIA DI BOLOGNA1
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI1
ISTITUTO PER LO STUDIO E LA PREVENZIONE ONCOLOGICA1
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT1
JOHNS HOPKINS UNIVERSITY1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KLINICKI BOLNICKI CENTAR RIJEKA1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS1
LUNDS UNIVERSITET1
MEDICAL RESEARCH COUNCIL1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MEDIZINISCHE UNIVERSITAET WIEN1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MINISTERIO DA SAUDE REPUBLICA PORTUGUESA1
MODUS OUTCOMES SAS1
MYELOMA PATIENTS EUROPE AISBL1
NATIONAL CANCER CENTER1
NHS NATIONAL SERVICES SCOTLAND1
NORDIC BIOSCIENCE1
OSLO UNIVERSITETSSYKEHUS HF1
OSPEDALE SAN RAFFAELE1
PFIZER LIMITED1
QUEEN'S UNIVERSITY AT KINGSTON1
RAND EUROPE COMMUNITY INTEREST COMPANY1
REGION HOVEDSTADEN1
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU1
RIJKSINSTITUUT VOOR VOLKSGEZONDHEIDEN MILIEUNATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT1
SERVICIO MADRILENO DE SALUD1
SORBONNE UNIVERSITE1
STATENS LEGEMIDDELVERK1
STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG1
STICHTING VUMC1
STIFTUNG FUR QUALITAT UND WIRTSCHAFTLICHKEIT IM GESUNDHEITSWESEN1
STIFTUNG TIERAERZTLICHE HOCHSCHULE HANNOVER1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE1
THE CRITICAL PATH INSTITUTE NON PROFIT CORPORATION1

Constancy:

Total number of partners: 136
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 133
Frequent / Rare Partner Ratio: 0.02

Project overview:

Start dateProjectacronymrolefundingpartners
2022-10-01Exploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application X-PANDparticipant3.797.5636
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2020-04-01DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES DECISIONparticipant6.000.00025
2020-03-16Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic I-MOVE-COVID-19participant2.808.16331
2020-01-01Improved Vaccination Strategies for Older Adults ISOLDAparticipant6.087.3147
2013-09-01Targeting cardiac fibrosis for heart failure treatment FIBRO-TARGETSparticipant6.000.00011
2012-01-01EPIC-CVD: Individualised CVD risk assessment: tailoring targeted and cost-effective approaches to Europe's diverse populations EPIC-CVDparticipant5.987.26630